Insights > Uncategorized

Uncategorized

Bionovis’s Acquisition of technologies to Produce Trastuzumab

8 de julho de 2020

Cescon, Barrieu, Flesch & Barreto and Demarest advised on the deal

Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer.

Download 


Áreas Relacionadas

Compartilhar

Uncategorized

VER TODOS

Client Alert

Ministry of the Environment releases a practical guide to raising funds for protected areas

6 de setembro de 2022

Client Alert

Brazilian Law No. 14,442/2022 introduces rules on meal allowance and the telework framework.

6 de setembro de 2022

Uncategorized

Law that establishes wage floors of nurses, nursing technicians, assistant nurses and midwives published

8 de agosto de 2022

Client Alerts

CCJC publishes opinion for approval of Bill No. 11,275/2018, which encourages claims for damages caused by anticompetitive practices in Brazil.

13 de julho de 2022